Cocaine self-administration in dopamine-transporter knockout mice BA Rocha, F Fumagalli, RR Gainetdinov, SR Jones, R Ator, B Giros, ... Nature neuroscience 1 (2), 132-137, 1998 | 700 | 1998 |
Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine YM Wang, RR Gainetdinov, F Fumagalli, F Xu, SR Jones, CB Bock, ... Neuron 19 (6), 1285-1296, 1997 | 439 | 1997 |
Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter RR Gainetdinov, F Fumagalli, SR Jones, MG Caron Journal of neurochemistry 69 (3), 1322-1325, 1997 | 417 | 1997 |
Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis RR Gainetdinov, SR Jones, F Fumagalli, RM Wightman, MG Caron Brain Research Reviews 26 (2-3), 148-153, 1998 | 322 | 1998 |
Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter F Fumagalli, RR Gainetdinov, KJ Valenzano, MG Caron Journal of Neuroscience 18 (13), 4861-4869, 1998 | 317 | 1998 |
Prepulse inhibition deficits and perseverative motor patterns in dopamine transporter knock-out mice: differential effects of D1 and D2 receptor antagonists RJ Ralph, MP Paulus, F Fumagalli, MG Caron, MA Geyer Journal of Neuroscience 21 (1), 305-313, 2001 | 307 | 2001 |
Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice F Fumagalli, RR Gainetdinov, YM Wang, KJ Valenzano, GW Miller, ... Journal of Neuroscience 19 (7), 2424-2431, 1999 | 287 | 1999 |
Stress during development: Impact on neuroplasticity and relevance to psychopathology F Fumagalli, R Molteni, G Racagni, MA Riva Progress in neurobiology 81 (4), 197-217, 2007 | 269 | 2007 |
The expanding role of BDNF: a therapeutic target for Alzheimer's disease? F Fumagalli, G Racagni, MA Riva The pharmacogenomics journal 6 (1), 8-15, 2006 | 226 | 2006 |
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter R Bossé, F Fumagalli, M Jaber, B Giros, RR Gainetdinov, WC Wetsel, ... Neuron 19 (1), 127-138, 1997 | 220 | 1997 |
Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice RR Gainetdinov, F Fumagalli, YM Wang, SR Jones, AI Levey, GW Miller, ... Journal of neurochemistry 70 (5), 1973-1978, 1998 | 211 | 1998 |
Pronounced hyperactivity, cognitive dysfunctions, and BDNF dysregulation in dopamine transporter knock-out rats D Leo, I Sukhanov, F Zoratto, P Illiano, L Caffino, F Sanna, G Messa, ... Journal of Neuroscience 38 (8), 1959-1972, 2018 | 196 | 2018 |
AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression S Chourbaji, MA Vogt, F Fumagalli, R Sohr, A Frasca, C Brandwein, ... The FASEB Journal 22 (9), 3129-3134, 2008 | 184 | 2008 |
Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions R Molteni, F Calabrese, F Bedogni, E Tongiorgi, F Fumagalli, G Racagni, ... International journal of neuropsychopharmacology 9 (3), 307-317, 2006 | 171 | 2006 |
Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease F Fumagalli, G Racagni, MA Riva The pharmacogenomics journal 6 (2), 95-104, 2006 | 161 | 2006 |
Corticostriatal brain‐derived neurotrophic factor dysregulation in adult rats following prenatal stress F Fumagalli, F Bedogni, J Perez, G Racagni, MA Riva European Journal of Neuroscience 20 (5), 1348-1354, 2004 | 161 | 2004 |
Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity R Molteni, F Fumagalli, V Magnaghi, M Roceri, M Gennarelli, G Racagni, ... Brain research reviews 37 (1-3), 249-258, 2001 | 148 | 2001 |
Chronic fluoxetine administration inhibits extracellular signal‐regulated kinase 1/2 phosphorylation in rat brain F Fumagalli, R Molteni, F Calabrese, A Frasca, G Racagni, MA Riva Journal of neurochemistry 93 (6), 1551-1560, 2005 | 143 | 2005 |
TAAR1 modulates cortical glutamate NMDA receptor function S Espinoza, G Lignani, L Caffino, S Maggi, I Sukhanov, D Leo, L Mus, ... Neuropsychopharmacology 40 (9), 2217-2227, 2015 | 128 | 2015 |
Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain ME Maragnoli, F Fumagalli, M Gennarelli, G Racagni, MA Riva Biological psychiatry 55 (11), 1095-1102, 2004 | 124 | 2004 |